bispecific KIR/ICOS antibody CD8 Treg modulator (Mozart therapeutics)

N/A

Report date: 2025/06/11 11:02:26

Base Information

Drug Namebispecific KIR/ICOS antibody CD8 Treg modulator (Mozart therapeutics)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionKIR receptors modulatorsCluster of differentiation 8 modulatorsImmunomodulators +[4] 
TargetsInducible T-cell costimulatorCluster of differentiation 8KIR receptors
Therapy Area/IndicationsAutoimmune DiseasesCrohn DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMozart Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMozart Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesCrohn DiseaseColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A